Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06420284

Immunological Parameters Between MRONJ Stages

Characterization of Immunological Parameters in Different Clinical Stages of Medication-Related Osteonecrosis of the Jaw

Status
Recruiting
Phase
Study type
Observational
Enrollment
42 (estimated)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study aims to conduct a detailed analysis of the immunological response profiles that emerge at different clinical stages of medication-related osteonecrosis of the jaw (MRONJ). The research seeks to understand how these responses influence the pathogenesis, staging, and treatment of MRONJ. Throughout the study, cytokine levels, inflammation markers, and other immunological parameters observed at various stages will be comprehensively assessed. The results of these analyses are expected to provide insights into how stage-specific immunological variables could play a role in the diagnosis and treatment of MRONJ.

Conditions

Timeline

Start date
2024-05-01
Primary completion
2025-02-01
Completion
2025-05-01
First posted
2024-05-20
Last updated
2024-05-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06420284. Inclusion in this directory is not an endorsement.

Immunological Parameters Between MRONJ Stages (NCT06420284) · Clinical Trials Directory